Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Crown BioScience
Crown BioScience
Activities:
Research & Development
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Finance
JSR Life Sciences companies form Japanese joint venture
Based in Tokyo, the venture will establish a local team led by an experienced General Manager, Hiroki Itou
Research & Development
Crown Bioscience opens oncology biomarker R&D centre in California
New custom-designed 32,000 sqft facility in San Diego to support the growth of both oncology biomarker and inflammation service portfolios
Research & Development
Crown Bioscience and Charles River agree to expand access to ZDSD rat model
The agreement enables greater global model availability for drug discovery in obesity, diabetes and metabolic syndrome
Research & Development
Crown Bioscience creates Center of Excellence for bioinformatics, big data and biomarker discovery
Services and capacity increase with new site opening
Research & Development
Crown Bioscience expands cardiovascular and metabolic disease research capability
The company offers new non-GLP services and translational rodent models at its expanded site in Louisiana
Research & Development
CrownBio expands humanised models for targeted immunotherapy
The humanised model expansion programme will begin with PD-1, CTLA-4 and CD137 models
Research & Development
Grant awarded to doctors researching innovative PDX models in immuno-oncology
Crown Bioscience awarded Dr Lavial and his colleagues the grant due to their project's potential to create breakthroughs in preclinical oncology strategies
Subscribe now